Skip to main content
. Author manuscript; available in PMC: 2011 Oct 21.
Published in final edited form as: Neuropsychopharmacology. 2009 Aug 26;34(13):2733–2745. doi: 10.1038/npp.2009.114

Figure 6. Pharmacological activation of the CB1 receptor within distinct amygdalar nuclei differentially affects stress-induced increases in corticosterone secretion.

Figure 6

Infusion of the CB1 receptor agonist HU-210 (2.5 μg) into the basolateral amygdala (BLA) suppressed stress-induced corticosterone secretion, in a CB1 receptor-dependent manner, while infusion of HU-210 into the medial amygdala (MeA) enhanced stress-induced corticosterone secretion. There was no effect of HU-210 infusion into the central nucleus of the amygdala (CeA). Values denoted are means ± SEM. * denotes significant differences (p < .05).

HHS Vulnerability Disclosure